Sangamo Therapeutics Inc
NASDAQ: SGMO
$1.96
+$0.01 (+0.5%)
Closing Price on November 21, 2024
SGMO Articles
Here are seven speculative biotech and biohealth stocks where analysts gave huge upside calls during the month of May 2017.
Published:
Last Updated:
Sangamo Therapeutics saw its shares skyrocket early on Thursday after a critical business update.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Baker Hughes, Brocade Communications, CenturyLink, Chevron, Juniper Networks and National Oilwell Varco.
Published:
Last Updated:
The top analyst upgrades, downgrades and initiations seen on Thursday morning include Apollo Global, ADM, Celgene, Total, Whole Foods and Targa Resources.
Published:
Last Updated:
Janney Montgomery Scott reiterated its Buy rating and $15 fair value estimate on Sangamo Biosciences as it brings multiple programs to the clinic this year.
Published:
Last Updated:
Stocks tried to stabilize on Monday, and Tuesday’s early indications were for Dow and S&P 500 futures to be up almost 1%. Last week’s sell-off may have been the worst opening week for stocks...
Published:
Last Updated:
These 50% to 100% implied upside picks from analysts are generally coming with far more risk than traditional Dow stocks, even if many of these are large cap stocks.
Published:
Last Updated:
Thursday’s top analyst upgrades, downgrades and initiations include AK Steel, CVS Health, Micron Technology, Nike, Oracle, Pandora Media, Sunrun and US Steel.
Published:
Last Updated:
Investors and traders alike always seem to be on the lookout for new investment ideas. With the S&P 500 and the Dow Jones Industrial Average having recently hit new highs, 24/7 Wall St. decided...
Published:
Last Updated:
The three major US stock indexes opened higher this morning, following on a positive debt sale by Portugal and some improvement in PMI numbers from Europe. ADP employment data did not meet...
Published:
Last Updated:
Active traders and day traders have many stocks to choose from this Monday morning. We are tracking news and moves in shares of Alcatel-Lucent (NYSE: ALU), US Airways Group, LLC. (NYSE:...
Published:
Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) has trumped Valeant Pharmaceuticals International, Inc. (NYSE: VRX) after it agreed to acquire Cephalon Inc. (NASDAQ: CEPH) in a $6.8 billion...
Published:
We are seeing more and more waves of secondary offerings continue to hit the Street since the stock market has held up. Many stocks are close to near-term highs and it seems they are raising cash in...
Published:
Last Updated: